PGAM1 and neoplasm: Although the possible role of PGAM1 in immunotherapeutic resistance and the brand-new CAR-T technology system has yet to be supported by experimental data, as a widespread pro-tumor effector molecule, it is significant to study its intrinsic relevance in tumor immune status and clinical translational effects.